Hypoxia-related gene expression profile in childhood acute lymphoblastic leukemia: prognostic implications

References

• Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011;29:551–565.
   PubMed Web of Science ®Google Scholar
• Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004;27:464–468.
   Web of Science ®Google Scholar
• Flotho C, Coustan-Smith E, Pei D, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 2007;15:1271–1277.
   Web of Science ®Google Scholar
• Scortegagna M, Morris MA, Oktay Y, et al. The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 2003;102:1634–1640.
   PubMed Web of Science ®Google Scholar
• Ke QD, Max C. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006;70:1469–1480.
   PubMed Web of Science ®Google Scholar
• Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000;157:411–421.
   PubMed Web of Science ®Google Scholar
• Harris A. Hypoxia – a key regulatory factor in tumor growth. Cancer 2002;2:38–47.
   PubMed Web of Science ®Google Scholar
• Winter SC, Shah KA, Han C, et al. The relation between hypoxia-inducible factor (HIF)-1α and HIF-2α expression with anemia and outcome in surgically treated head and neck cancer. Cancer 2006;107:757–766.
   PubMed Web of Science ®Google Scholar
• Wu XH, Qian C, Yuan K. Correlations of hypoxia-inducible factor-1α/hypoxia-inducible factor-2α expression with angiogenesis factors expression and prognosis in non-small cell lung cancer. Chin Med J 2011;124:11–18.
   PubMed Web of Science ®Google Scholar
• Noguera R, Fredlund E, Piqueras M, et al. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization. Clin Cancer Res 2009;15:7130–7136.
   PubMed Web of Science ®Google Scholar
• Klein A, Flugel D, Kietzmann T. Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1. Mol Biol Cell 2008;19:3667–3675.
   Google Scholar
• Cammareri P, Scopelliti A, Todaro M, et al. Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. Cancer Res 2010;70:4655–4665.
   PubMedGoogle Scholar
• Failes TW, Mitic G, Abdel-Halim H, et al. Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells. PLoS One 2012;7:e30734.
   Web of Science ®Google Scholar
• Brandalise SR, Pinheiro VR, Aguiar SS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children:randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99. J Clin Oncol 2010;28:1911–1918.
   PubMed Web of Science ®Google Scholar
• Silveira VS, Scrideli CA, Moreno DA, et al. Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia. Leuk Lymphoma 2013;54:310–314.
   PubMed Web of Science ®Google Scholar
• Beillard E, Pallisgaard N, van der Velden VHJ, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using “real-time” quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Leukemia 2003;17:2474–2486.
   PubMed Web of Science ®Google Scholar
• Valceckiene V, Kontenyte R, Jakubauskas A, et al. Selection of reference genes for quantitative polymerase chain reaction studies in purified B cells from B cell chronic lymphocytic leukaemia patients. Br J Haematol 2010;151:232–238.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Wellmann S, Guschmann M, Griethe W, et al. Activation of the HIF pathway in childhood LLA, prognostic implications of VEGF. Leukemia 2004;18:926–933.
   PubMed Web of Science ®Google Scholar
• Paydas S, Ergin M, Erdogan S, et al. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leuk Res 2008;32:1424–1430.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang L, Zhou D, et al. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified. Leuk Lymphoma 2011;52:46–52.
   PubMed Web of Science ®Google Scholar
• Demacq C, Vasconcellos VB, Izidoro-Toledo TC, et al. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). Clin Chim Acta 2010;411:1335–1340.
   PubMed Web of Science ®Google Scholar
• Avramis IA, Panosyan EH, Dorey F, et al. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962. Clin Cancer Res 2006;12:6978–6984.
   PubMed Web of Science ®Google Scholar
• Benito J, Shi Y, Szymanska B, et al. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS One 2011;6:e23108.
   PubMed Web of Science ®Google Scholar
• Frolova O, Samudio I, Benito JM, et al. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment. Cancer Biol Ther 2012;13:858–870.
   PubMed Web of Science ®Google Scholar
• Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008;15:678–685.
   PubMed Web of Science ®Google Scholar
• Osada R, Horiuchi A, Kikuchi N, et al. Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma. Hum Pathol 2007;38:1310–1320.
   PubMed Web of Science ®Google Scholar
• Selvendiran K, Bratasz A, Kuppusamy ML, et al. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer 2009;125: 2198–2204.
   PubMed Web of Science ®Google Scholar
• Keith B, Johnson RS, Simon MC. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2011; 12:9–22.
   PubMed Web of Science ®Google Scholar
• Evens AM, Sehn LH, Farinha P, et al. Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2010;28: 1017–1024.
   PubMed Web of Science ®Google Scholar
• Lidgren A, Hedberg Y, Grankvist K, et al. The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin Cancer Res 2005:11:1129–1135.
   PubMed Web of Science ®Google Scholar
• Fillies T, Werkmeister R, van Diest PJ, et al. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 2005;5:84.
   PubMed Web of Science ®Google Scholar
• Hartsink-Segers SA, Zwaan CM, Exalto C, et al. Aurora kinases in childhood acute leukemia: the promise of Aurora B as therapeutic target. Leukemia 2013;27:560–568.
   PubMed Web of Science ®Google Scholar
• Frolova O, Samudio I, Benito JM, et al. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment. Cancer Biol Ther 2012;13:858–870.
   PubMed Web of Science ®Google Scholar